Deep Track Capital, LP 13D and 13G filings for Heron Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 08:46 am Sale | 2023-12-31 | 13G | Heron Therapeutics, Inc. HRTX | Deep Track Capital, LP | 0 0.000% | -12,232,267 (Position Closed) | Filing |
| 2022-08-19 4:03 pm Purchase | 2022-08-09 | 13G | Heron Therapeutics, Inc. HRTX | Deep Track Capital, LP | 12,232,267 9.990% | 12,232,267 (New Position) | Filing |